Extracellular pH controls pre-mRNA alternative splicing of tenascin-C in normal, but not in malignantly transformed, cells

International Journal of Cancer

Volumn 66, Issue 5, 1996, Pages 632-635

  Borsi, Laura ^a   Allemanni, Giorgio ^a   Gaggero, Barbara ^a   Zardi, Luciano ^a  

^a UNIVERSITY OF GENOA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA PRECURSOR; TENASCIN;

ALTERNATIVE RNA SPLICING; ARTICLE; CANCER CELL; CELL PH; CELL TRANSFORMATION; CONTROLLED STUDY; EXTRACELLULAR MATRIX; FIBROBLAST; GENE CONTROL; HUMAN; HUMAN CELL; PRIORITY JOURNAL;

ALTERNATIVE SPLICING; CELL TRANSFORMATION, NEOPLASTIC; CELLS, CULTURED; CULTURE MEDIA; CYTOKINES; EXTRACELLULAR SPACE; FIBROBLASTS; HUMANS; HYDROGEN-ION CONCENTRATION; ISOMERISM; REFERENCE VALUES; RNA PRECURSORS; RNA, MESSENGER; TENASCIN;

EID: 0030008642     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19960529)66:5<632::AID-IJC9>3.0.CO;2-U     Document Type: Article

References (31)

1. AUSTIN, C. and WRAY, S., Extracellular pH signals affect rat vascular tone by rapid transduction into intracellular pH changes. Amer. J. Physiol., 466, 1-8 (1993).
2. + exchanger is constitutively activated in P19 embryonal carcinoma cells, but not in a differentiated derivative. J. biol. Chem., 262, 9621-9628 (1987).
3. BORSI, L., BALZA, E., CASTELLANI, P., CARNEMOLLA, B., PONASSI, M., QUERZÉ, G. and ZARDI, L., Cell-cycle dependent alternative splicing of the tenascin primary transcript. Cell Adhes. Comm . 1, 307-317 (1994).
4. BORSI, L., BAIZA, E., GAGGERO, B., ALLEMANNI, G. and ZARDI, L., The alternative splicing pattern of the tenascin-C pre-mRNA is controlled by the extracellular pH. J. biol. Chem., 270, 6243-6245 (1995).
5. BORSI, L., CARNEMOLLA, B., NICOLÒ, G., SPINA, B., TANARA, G. and ZARDI, L., Expression of different tenascin isoforms in normal, hyperplastic and neoplastic human breast tissues. Int J. Cancer. 52, 688-692 (1992).
6. CARNEMOLLA, B., BORSI, L., BANNIKOV, G., TROYANOVSKY, S. and ZARDI, L., Comparison of human tenascin expression in normal. SV-40 transformed and tumor derived cell lines. Europ. J. Biochem., 205, 561-567 (1992).
7. CARNEMOLLA, B., SIRI, A., BORSI, L. and ZARDI, L., Tenascin-C in disease. In: K. Crossin (ed.). Tenascin and other counteradhesive molecules of the extracellular matrix, pp. 89-108, Harwood, Amsterdam (1996).
8. CASTELLANI, P., VIALE, G., DORCARATTO, A., NICOLÒ, G., KACZMAREK, J., QUERZÉ, G. and ZARDI, L., The fibronectin isoform containing the ED-B oncofetal domain: a marker of angiogenesis. Int. J. Cancer, 59, 612-618 (1994).
9. CHIQUET-EHRISMANN, R., Tenascin and other adhesion-modulating proteins in cancer. Sem. Cancer Biol., 4, 301-310 (1993).
10. CHIOUET-EHRISMANN, R., MATSUOKA, Y., HOFER, U., SPRING, J., BERNASCONI, C. and CHIQUET, M., Tenascin variants: differential binding to fibronectin and distinct distribution in cell cultures and tissues. Cell Regul., 2, 927-938 (1991).
11. CHUNG, C.Y. and ERICKSON, H.P., Cell surface annexin II is a high affinity receptor for the alternatively spliced segment of tenascin-C. J Cell Biol., 126, 539-548 (1994).
12. EDELMAN, G.M. and JONES, F.S., Cytotactin - a morphoregulatory molecule and a target for regulation by homeobox gene products. Trends Biochem Sci., 17, 228-232 (1992).
13. EKBLOM, G.M. and AUFDERHEIDE, E., Stimulation of tenascin expression in mesenchyme by epithelial-mesenchymal interactions. Int. J. Dev. Biol., 33, 71-79 (1989).
14. ERICKSON, H.P. and BOURDON, M.A., Tenascin: an extracellular matrix protein prominent in specialized embryonic tissues and tumors, Ann Rev. Cell. Biol. 5, 71-92 (1989).
15. FUERSTENBERG, S., LEITNER, I., SCHROEDER, C., SCHWARZ, H., VENNSTRÖM, B. and BEUG, H., Transcriptional repression of band 3 and CAII in v-erbA transformed erythroblasts accounts for an important part of a leukaemic phenotype. EMBO J., 11, 3355-3365 (1992).
16. GRIFFITHS, J.R., Are cancer cells acidic? Brit. J. Cancer, 64, 425-427 (1991).
17. + exchange and growth factor-induced cytosolic pH changes. Role in cellular proliferation. Biochim. Biophys. Acta, 988, 73-97 (1989).
18. GULCHER, J.R., NIES, D.E., MARTON, L.S. and STEFANSSON, K., An alternatively spliced region of the human hexabrachion contains a repeat of potential N-glycosylation sites. Proc. nat. Acad. Sci. (Wash.). 86, 1588-1592 (1989).
19. 3 exchange in NIH-3T3 fibroblasts. J. biol. Chem., 269, 4116-4124 (1994).
20. L'ALLEMAIN, G., PARIS, S. and POUYSSÉGUR, J., Growth factor action and intracellular pH regulation in fibroblasts. J. biol. Chem., 259, 5809-5815 (1984).
21. LEPRINI, A., QUERZÉ, G. and ZARDI, L., Tenascin isoforms: possible targets for diagnosis and therapy of cancer and mechanisms regulating their expression. Perspect. Dev. Neurobiol., 2, 317-123 (1994).
22. MELLERGÅRD, P., OU-YANG, Y. and SIESKO, B.K., Relationship between intra- and extracellular pH in primary cultures of astrocytes. Amer. J. Physiol., 267, C581-C589 (1994).
23. MURPHY-ULLRICH, J.E., LIGHTNER, V.A., AUKHIL, I., YAN, Y.Z., ERICKSON, H.P. and HOOK, M., Focal adhesion integrity is downregulated by the alternatively spliced domam of human tenascin. J. Cell Biol., 115, 1127-1130 (1991).
24. SCHWÖGLER, S., ODENTHAL, M., MEYER ZUM BÜSCHENFELDE, K.-H. and RAMADORI, G., Alternative splicing products of the tenascin gene distinguish rat liver fat storing cells from arterial smooth muscle cells and skin fibroblasts. Biochem. biophys. Res. Comm., 185, 768-775 (1992).
25. SIRI, A., CARNEMOLLA, B., SAGINATI, M., LEPRINI, A., CASARI, G., BARALLE, F. and ZARDI, L., Human tenascin: primary structure, pre-mRNA splicing patterns and localization of the epitopes recognized by two monoclonal antibodies. Nucl. Acids Res., 19, 525-531 (1991).
26. SRIRAMARAO, P. and BOURDON, M.A., A novel tenascin type III repeat is part of a complex of tenascin mRNA alternative splices. Nucl. Acids Res., 21, 163-168 (1993).
27. TUCKER, R.P., HAMMERBACK, J.A., JENRATH, D.A., MACKIE, E.J. and XU, Y., Tenascin expression in the mouse: in situ localization and induction in vitro by bFGF. J. Cell Sci., 104, 69-73 (1993).
28. VAUGHAN, L., WEBER, P., D'ALESSANDRI, L., ZISCH, A.H. and WINTERHALTER, K.H., Tenascin-contactin/FH interactions: a clue for a developmental role? Perspect. Dev. Neurobiol. 2, 43-52 (1994).
29. VAUPEL, P., KALLINOWSKI, F. and OKUNIEFF, P., Blood flow, oxygen and nutrient supply, and metabolic microenvironment of human tumors: a review. Cancer Res., 49, 6449-6465 (1989).
30. WELLER, A., BECK, S. and EKBLOM, P., Amino acid sequence of mouse tenascin and differential expression of two tenascin isoforms during embryogenesis. J. Cell Biol., 112, 355-362 (1991).
31. ZISCH, A.H., D'ALESSANDRI, L., RANSCHT, B., FALCHETTO, R., WINTERHALTER, K.H. and VAUGHAN, L., Neuronal cell adhesion molecule contactin/FH binds to tenascin via its immunoglobulin domains. J. Cell Biol., 119, 203-213 (1992).